In the Last 7 days there's been 9 influencers like BiotechSweden and adamfeuerstein, discussing topics such as #BioTech, #nasaand #AmericasMostJUST.



Trends


Top hashtags

Top influencers

  BiotechSweden
  adamfeuerstein
  matthewherper
  BIODeutschland
  CDRLifeSciences
  HealthcareLdr
  Merck
  NatureBiotech
  ldtimmerman

Top sources

source img biospace.com
source img fiercebiotech.com
source img finance.yahoo.com
source img in.reuters.com
source img timesofindia.indiatimes.com
source img timmermanreport.com
source img businesstoday.in
source img cbsnews.com
source img deshgujarat.com

News

The two months in 1980 that shaped the future of biotech

On Oct 17, 2020
@adamfeuerstein shared
RT @HankGreelyLSJU: I've got a fun piece in @statnews First Opinions on Oct-Dec 1980: 2 months that shaped biotech. https://t.co/oo5jhLy0wt Five big things happened in 59 days. Is it meaningful or coincidence? I don't know. Is it important? Probably not, but I think it's interesting. You might, too.
Open

Five events in a two-month span in 1980 propelled the nascent biotech industry and university biotech research into the future.

www.statnews.com
On Oct 17, 2020
@adamfeuerstein shared
RT @HankGreelyLSJU: I've got a fun piece in @statnews First Opinions on Oct-Dec 1980: 2 months that shaped biotech. https://t.co/oo5jhLy0wt Five big things happened in 59 days. Is it meaningful or coincidence? I don't know. Is it important? Probably not, but I think it's interesting. You might, too.
Open

The two months in 1980 that shaped the future of biotech

The two months in 1980 that shaped the future of biotech

Five events in a two-month span in 1980 propelled the nascent biotech industry and university biotech research into the future.


On Oct 14, 2020
@HealthcareLdr shared
Artificial Intelligence will Transform Healthcare Within our Lifetime https://t.co/dCgCk5q1nc @LinkedInEditors #Healthcare #ArtificialIntelligence #HealthTech #PatientEngagement #DigitalHealth https://t.co/77gzN5Xr6l
Open

Artificial Intelligence will Transform Healthcare Within our Lifetime

Artificial Intelligence will Transform Healthcare Within our Lifetime

In the decade ahead, in the 2020s, AI will surpass people and doctors in diagnosis and predicting medical outcomes. AI is promising to see patterns in images that will correlate with ...

On Oct 16, 2020
@BIODeutschland shared
RT @sirionbiotechmu: We are proud to announce that @Mustang_Bio has licensed our #lentiviral #tranduction enhancer LentiBOOST™ for use in the development of MB-207, a lentiviral gene therapy to treat patients with #XSCID. https://t.co/7kj8Ot8zST #viralvectors #raredisease https://t.co/HHt9aOeYY6
Open

Mustang Bio Licenses LentiBOOST™ Technology from SIRION Biotech

Mustang Bio Licenses LentiBOOST™ Technology from SIRION Biotech

Mustang to leverage LentiBOOST™ for the development of MB-207 lentiviral gene therapy

On Oct 19, 2020
@Prof_ChrisMason shared
RT @OriBiotech: Some more great coverage of our $30m Series A fundraise in @pharmiweb_com - thank you for the write up. Check out the article here: https://t.co/OLNSH5mb6j #celltherapy #genetherapy #manufacturingbrighterfutures
Open

Ori Biotech Raises $30 Million in Series A Financing to Advance Innovation in Cell and Gene Therapy Manufacturing

Ori Biotech Raises $30 Million in Series A Financing to Advance Innovation in Cell and Gene Therapy Manufacturing

Syndicate led by leading life science investors Northpond Ventures alongside Octopus VenturesOctober 14, 2020, London, UK and Woodcliff Lake, NJ - Ori Biotech Ltd (Ori), a leading innovator ...

On Oct 18, 2020
@NatureBiotech shared
RT @UMassMedical: Guangping Gao, PhD, & #NobelPrize2020 winner Jennifer Doudna are both on @NatureBiotech's list of top translational biotech researchers for 2019. The #genetherapy pioneer & director of @UMMSGeneTherapy was on the 2018 list too. https://t.co/DQLXMsOuro @nresearchnews #UMassMedNews
Open

Guangping Gao makes list of Nature Biotechnology Top 20 translational researchers

Guangping Gao makes list of Nature Biotechnology Top 20 translational researchers

An influential scientific journal’s list of top translational biotech researchers for 2019 includes Guangping Gao, PhD. Rankings are based on total patents for the year, among other ...

On Oct 19, 2020
@Prof_ChrisMason shared
RT @OriBiotech: More great coverage on our $30m fundraising announcement - big thanks to @BioProcessIntl for this write up: https://t.co/cvzL7XeZ3U #celltherapy #genetherapy #manufacturingbrighterfutures
Open

With $30m in hand, Ori looks to advance closed cell therapy tech

With $30m in hand, Ori looks to advance closed cell therapy tech

Ori Biotech will use $30 million to finalize and test its closed and automated cell and gene therapy technology.

On Oct 15, 2020
@BiotechSweden shared
Chutes & Ladders—Sanofi CSO Nabel steps down in favor of insider Nestle https://t.co/5isYu3sSIA https://t.co/6OhRUQUxFa
Open

Chutes & Ladders—Sanofi CSO Nabel steps down in favor of insider Nestle

Chutes & Ladders—Sanofi CSO Nabel steps down in favor of insider Nestle

Sanofi's CSO Nabel steps down from role; BioMarin adds Eggan to head early research; Shams joins ProQR as CSO.

On Oct 15, 2020
@adamfeuerstein shared
@juliaskripkaser This will make you literally laugh out loud. https://t.co/Ojs5XxSDd9
Open

DEDUCED RECKONING: Northwest Biotherapeutics is finally ready for prime time

DEDUCED RECKONING: Northwest Biotherapeutics is finally ready for prime time

Dr. Alton Boynton set out to harness the body’s own immune system to fight cancer.

On Oct 14, 2020
@BiotechSweden shared
Bharat Biotech fast-tracks Covid-19 vaccine development; company cuts phase-2 size, will seek nod for phase-3 #BioTech #ui via https://t.co/2sI0UxJbpn https://t.co/x7E5Lm3xGA
Open

Bharat Biotech fast-tracks Covid-19 vaccine development; company cuts phase-2 size, will seek nod for phase-3

Bharat Biotech fast-tracks Covid-19 vaccine development; company cuts phase-2 size, will seek nod for phase-3

Instead of testing the vaccine candidate on 750 healthy volunteers in Phase-2, as approved for its clinical trial protocol, the company will now be testing it on just 380 volunteers. ...

On Oct 15, 2020
@BiotechSweden shared
RT @NovAccessGlobal: https://t.co/onXMuM3q1B #biotech #therapeutics #diagnostics #cancerresearch #cancertreatment #ivst #xsnx $IVST $XSNX https://t.co/eYwlgNvDDy
Open

NovAccess Global Appoints Dwain Irvin, Ph.D., MPH as New Chief Executive Officer

NovAccess Global Appoints Dwain Irvin, Ph.D., MPH as New Chief Executive Officer

Leadership by world-renown cancer researcher signals commitment to driving current and forthcoming biomedical opportunitiesCLEVELAND, OH / ACCESSWIRE / October 15, 2020 / NovAccess Global, ...

Browse topics

Get updates live! Follow us on

Choose your newsletters

On Oct 18, 2020
@BiotechSweden shared
Serum Institute, Bharat Biotech to start clinical trials of nasal COVID-19 vaccines #BioTech #nasa via https://t.co/2sI0UxJbpn https://t.co/2g9mNGedef
Open

Serum Institute, Bharat Biotech to start clinical trials of nasal COVID-19 vaccines

Serum Institute, Bharat Biotech to start clinical trials of nasal COVID-19 vaccines

Coronavirus vaccine: While there are no intranasal COVID-19 vaccines under trial in India at the moment, the two companies will pursue clinical trials of such vaccines in India in the ...

On Oct 18, 2020
@BiotechSweden shared
RT @ReutersIndia: Serum Institute, Bharat Biotech to begin trial of intranasal COVID-19 vaccine soon: Vardhan https://t.co/a3l8dLg8zn
Open

Serum Institute, Bharat Biotech to begin trial of intranasal COVID-19 vaccine soon: Vardhan

Serum Institute, Bharat Biotech to begin trial of intranasal COVID-19 vaccine soon: Vardhan

Serum Institute of India and Bharat Biotech are expected to pursue late stage clinical trials of intranasal COVID-19 vaccines in the coming months once they receive regulatory approval, ...

On Oct 19, 2020
@BiotechSweden shared
Serum Institute, Bharat Biotech to begin trial of intranasal Covid vaccine soon: Harsh Vardhan #BioTech #nasa via https://t.co/2sI0UxJbpn https://t.co/IAqpAfK2nH
Open

Serum Institute, Bharat Biotech to begin trial of intranasal Covid vaccine soon: Harsh Vardhan

Serum Institute, Bharat Biotech to begin trial of intranasal Covid vaccine soon: Harsh Vardhan

India News: NEW DELHI: Serum Institute of India and Bharat Biotech are expected to pursue late stage clinical trials of intranasal Covid-19 vaccines in the coming.

On Oct 20, 2020
@SWLifeSciences shared
With Bases Loaded, NervGen Swings for the Fences in Traumatic Brain Injury: https://t.co/epQpNDhZqc Is there anything intracellular sigma peptide, the company's lead agent, can't do, asks Dr. KSS of https://t.co/ElzAwnNCv7. $NGEN.CA $NGENF #TBI #healthcare #stocks @NervgenC https://t.co/IU2UbaieWS
Open

With Bases Loaded, NervGen Swings for the Fences in Traumatic Brain Injury Contributed Opinion

With Bases Loaded, NervGen Swings for the Fences in Traumatic Brain Injury Contributed Opinion

Is there anything intracellular sigma peptide, the company's lead agent, can't do, asks Dr. KSS, MD, PhD, editor-in-chief of BioPub.co.

On Oct 19, 2020
@matthewherper shared
Fauci admits administration has restricted his media appearances, says he's not surprised Trump got COVID. https://t.co/AV5LBRCHCs
Open

Fauci admits administration has restricted his media appearances, says he's not surprised Trump got COVID

Fauci admits administration has restricted his media appearances, says he's not surprised Trump got COVID

In a wide-ranging 60 Minutes interview, Dr. Anthony Fauci expresses his frustration with a Trump campaign ad; explains why, early in the pandemic, masks were largely recommended for health ...

On Oct 15, 2020
@ldtimmerman shared
Corporate leaders under pressure to start taking action on diversity, from leaders in NY, Calif. and asset managers with $5.9 trillion under management. Latest from @karlsimpson @liftstream https://t.co/bf45wOB7eJ
Open

Corporate Leaders Face Pressure from Investors, Regulators to Act on Diversity

Corporate Leaders Face Pressure from Investors, Regulators to Act on Diversity

Over the summer, when George Floyd’s horrific death and the disparities of the pandemic combined to spur a new national reckoning with systemic racial injustice, many CEOs issued ...

On Oct 16, 2020
@BiotechSweden shared
RT @DeshGujarat: Gujarat govt nod to Bharat Biotech for Covid19 vaccine trials in five hospitals https://t.co/WOvB9CQ5AO
Open

Gujarat govt nod to Bharat Biotech for Covid19 vaccine trials in five hospitals

Gujarat govt nod to Bharat Biotech for Covid19 vaccine trials in five hospitals

Gandhinagar: Bharat Biotech has received permission from the State Health and Family Welfare department of Gujarat to conduct Phase-III efficiency and safety clinical trials of COVID19 ...

On Oct 18, 2020
@BiotechSweden shared
Manufacturing a Personalized Cellular Universe: 3D Bioprinting in the Biotech Industry #BioTech via https://t.co/2sI0UxJbpn https://t.co/MUC6gBCpru
Open

Manufacturing a Personalized Cellular Universe: 3D Bioprinting in the Biotech Industry

Manufacturing a Personalized Cellular Universe: 3D Bioprinting in the Biotech Industry

By using naturally-derived scaffolds, human cells and other biocompatible materials, 3D bioprinting has ushered in opportunities for researchers to design, print and optimize patient ...

On Oct 19, 2020
@Prof_ChrisMason shared
RT @OriBiotech: Find out what our CEO Jason Foster has to say about our recent $30m Series A fund round, and what it means for the future of Ori. Check out his latest LinkedIn article here: https://t.co/RzYRnITq6e
Open

After Series A: What is next for Ori?

After Series A: What is next for Ori?

After 6 months of hard work through the COVID lockdown, the Ori Biotech team is delighted to announce that we have successfully closed a $30M (£23M) Series A financing round.  Our Series A ...

On Oct 19, 2020
@BiotechSweden shared
https://t.co/epZmhgPAfh
Open

Femtech Trailblazers Talk Innovation and Capitalization to Meet Women’s Underserved Needs

Femtech Trailblazers Talk Innovation and Capitalization to Meet Women’s Underserved Needs

Femtech represents significant growth opportunities for biotech companies, but is still under the radar for most investors. None-the-less, pioneering companies are emerging to address this ...

On Oct 13, 2020
@CDRLifeSciences shared
RT @Oxurion: @Oxurion NV appoints Tom Graney, CFA as Chief Financial Officer https://t.co/cT09u7n7OG #retina #CFO #leadership #diabeticeyedisease #nextgenerationtherapies #DME #wAMD https://t.co/4M4MBzBDjG
Open

Oxurion NV appoints Tom Graney, CFA as Chief Financial Officer

Oxurion NV appoints Tom Graney, CFA as Chief Financial Officer

Boston-based former Vertex and Generation Bio CFO Brings Significant Operational, US Capital Markets and Investor Relations Expertise